Bacteria-Driven Hypoxia Targeting for Combined Biotherapy and Photothermal Therapy

Wenfei Chen1, Ying Wang1, Ming Qin1

  • 1Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy , Sichuan University , Chengdu 610041 , P.R. China.

ACS Nano
|May 23, 2018
PubMed

Insights

This study combined Salmonella VNP20009 bacteria with polydopamine for enhanced photothermal therapy. The novel approach effectively eliminated malignant melanoma tumors in mice without relapse, showcasing synergistic anticancer effects.

Area of Science:

  • Biomedical Engineering
  • Oncology
  • Materials Science

Background:

  • Salmonella VNP20009 selectively targets hypoxic tumor cores, but its clinical application is limited by weak efficacy and toxicity.
  • Polydopamine (pDA) offers photothermal properties for cancer therapy.
  • Combining VNP20009 biotherapy with pDA-mediated photothermal therapy (PTT) presents a novel strategy to enhance antitumor effects.

Purpose of the Study:

  • To investigate the synergistic antitumor efficacy of VNP20009 combined with polydopamine-mediated photothermal therapy against malignant melanoma.
  • To evaluate the safety and effectiveness of this combined therapeutic approach in a preclinical mouse model.

Main Methods:

  • Salmonella VNP20009 was coated with polydopamine (pDA) via oxidation and self-polymerization.
  • The pDA-coated VNP20009 was administered intravenously to tumor-bearing mice.
  • Near-infrared (NIR) laser irradiation was applied to induce photothermal effects in the tumors.

Main Results:

  • The pDA-coated VNP20009 effectively targeted hypoxic tumor regions.
  • Combined VNP20009 biotherapy and pDA-mediated PTT resulted in complete tumor elimination without relapse or metastasis in a single treatment.
  • A synergistic effect was observed, where VNP20009 and pDA enhanced each other's therapeutic capabilities.

Conclusions:

  • The combination of Salmonella VNP20009 biotherapy and polydopamine-mediated photothermal therapy is a highly effective strategy for treating malignant melanoma.
  • This approach overcomes the limitations of VNP20009 monotherapy, offering enhanced antitumor efficacy and reduced toxicity.
  • The synergistic interaction between VNP20009 and pDA provides a promising platform for developing novel cancer treatments.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Hypoxia01:23

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.2K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
ATP Driven Pumps I: An Overview01:27

ATP Driven Pumps I: An Overview

ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
9.9K
Group Therapy01:26

Group Therapy

Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
454